Navigation Links
Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study
Date:5/22/2012

SUNNYVALE, Calif. and BELGRADE, Serbia, May 22, 2012 /PRNewswire/ -- Sorbent Therapeutics, Inc. a biopharmaceutical company developing therapies for cardiovascular and renal diseases, presented positive data from its Phase 2a clinical study of CLP1001.  In the study of 111 heart failure patients with chronic kidney disease, CLP1001 demonstrated improvement in heart failure symptoms as compared to placebo.   

Data from the randomized, double-blind Phase 2a study were presented in an oral session at the Annual European Society of Cardiology Heart Failure Congress 2012 in Belgrade, Serbia.  A manuscript detailing the results of the Phase 2a clinical study, titled "A Double-Blind, Randomized, Parallel, Placebo Controlled Study Examining the Effect of Cross-linked Polyelectrolyte (CLP) in Heart Failure Patients with Chronic Kidney Disease," will be published in the June 2012 issue of the European Journal of Heart Failure.

"Addressing the symptoms of heart failure is critically important to patients' quality of life.  The beneficial effects of CLP1001 represent a meaningful improvement in heart failure signs and symptoms in a difficult-to-treat patient population," said Maria Rosa Costanzo, M.D., F.A.C.C., Medical Director of the Edward Center for Advanced Heart Failure in Naperville, Illinois and member of Sorbent's Medical Advisory Board.  "I am excited by the data obtained from this trial and look forward to CLP1001's continued clinical development in heart failure."

"Despite available therapies, heart failure is the most common cause of hospitalizations in patients 65 years and older in the U.S.  The positive findings from this Phase 2a clinical study of CLP1001 are highly promising with regard to reducing fluid retention and shortness of breath, which are considered critical measures of success in the treatment of heart failure patients," said Howard C. Dittrich, M.D., F.A.C.C., Sorbent's Chief Medical
'/>"/>

SOURCE Sorbent Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Allied Healthcare Announces Litholyme(TM) -- New CO2 Absorbent Used in Anesthesia
2. Reportlinker Adds US Enzyme-Linked Immunosorbent Assay (ELISA) Industry
3. Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million
4. CytoSorbents Corporation to Exhibit at the Advanced Technology Applications for Combat Casualty Care Conference
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
8. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
9. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
10. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Mass. , Aug. 21, 2014  Decision ... COPD,  physicians in Brazil ... follow clinical guidelines and commonly prescribe long-acting beta-agonist ... although they do so within current severe cost/coverage ... (FDCs) that are expected to launch in these ...
(Date:8/21/2014)... 2014 /PRNewswire-iReach/ -- ScriptPro has been certified by ... Common Security Framework (CSF). According to Russ ... "We appreciate this rigorous, top-to-bottom audit. Security-minded customers ... certification signifies. Our business partners need to know ... CERTIFICATION PROCESS: ScriptPro,s internal security processes and controls ...
(Date:8/21/2014)... BreedIT Corp., (OTCQB: BRDT) ... worldwide license holder and distributor of highly sophisticated ... today is pleased to announce the formation of ... a leading Israeli medical Cannabis breeder. ... breeds of medical Cannabis to meet the requests ...
Breaking Medicine Technology:Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3ScriptPro Achieves HITRUST Certification 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4
... 13 An 80-year-old lung cancer patient has become ... using a new linear accelerator that can deliver precise ... Center carried out the treatment last week, becoming only ... using TrueBeam™ from Varian Medical Systems (NYSE: VAR). ...
... CANTON, Ohio, Sept. 13 AultCare has been ... in partnership with Cardiocom, released a white paper ... The paper describes the structure of ... and patient. Improved patient self-management has resulted in ...
Cached Medicine Technology:Leading Dutch Cancer Center Commences Treatments Using New TrueBeam from Varian Medical Systems 2Leading Dutch Cancer Center Commences Treatments Using New TrueBeam from Varian Medical Systems 3AultCare/Cardiocom® White Paper Shows Telehealth Services Reduce ER Visits and Inpatient Stays for Patients 2
(Date:8/21/2014)... The world wound care market is expected to ... USD 18.3 billion by 2019, posting a CAGR of ... growth include governments’ contribution to the development of wound ... ageing population. However, the growth could be restrained by ... America leads the global wound care market, with the ...
(Date:8/21/2014)... August 21, 2014 The second ... by Boston Scientific has begun in Massachusetts state ... trial. The Rottenstein Law Group LLP, a national ... claims of harm stemming from the implantation of ... for compensation for injuries suffered at http://www.wehelpwomen.com/transvaginal-mesh/ ...
(Date:8/21/2014)... 2014 Lauren Collura, a mother of two ... to the Boardwalk” Facebook sweepstakes. Lauren, her husband, and two ... beachfront house in Lavallette beginning this Saturday. , This ... sweepstakes. Last year, Horizon Blue Cross Blue Shield of New ... Sandy and decided to make it a new summer tradition. ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 The ... this year's conference will focus on the Future ... for research, innovation and commercialization. , With the ... SALSS combines the worlds' of business and science. ... widely recognized Summit, gathering a diverse community with ...
(Date:8/21/2014)... (HealthDay News) -- In a new review of seafood ... eating tuna due to concerns about mercury exposure. ... only to shrimp as the most commonly eaten seafood ... avoid all tuna," Jean Halloran, director of food policy ... Reports, said in a news release from the group. ...
Breaking Medicine News(10 mins):Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 3Health News:Transvaginal Mesh Lawsuit News: Second Boston Scientific Mesh Bellwether Trial Begins, The Rottenstein Law Group LLP Reports 2Health News:The Tenth Swedish-American Life Science Summit, takingplace in Stockholm, Sweden, August 20-22nd, will focus on The Future of Medicine 2Health News:Consumer Reports Advises Pregnant Women to Avoid Tuna 2
... get boosted by a 'super' form of an enzyme called Akt1. ... cells. These cells are also referred to as the main switch ... to attack a tumor. This was divulged in a report that ... the journal Nature Biotechnology. Researchers from Baylor College of Medicine conducted ...
... appears to be something of a great divide in terms ... Britons and their health conscious watch –what –you -eat// fellow ... worried about rocketing obesity figures that cost the NHS around ... new plan.,This involves trusts funded by them to get people ...
... magnet, that is currently used in many commercial gadgets ... implanted heart devices,// like the pacemaker, with fatal consequences. ... magnets were introduced into the market recently and are ... more familiar, dull grey iron magnets. Since the cost ...
... tennis elbow ask them to alter the grip size of ... the muscle firing patterns in the forearm demonstrates that grip ... ,Researchers apparently have "gotten a grip" on the relationship ... of the grip on the racket a player uses. ...
... who take breaks in antiretroviral (ARV) drug treatment face greater ... take their medicine regularly, according to a new study in ... end a long debate on the value of 'drug holidays', ... a popular strategy in the war against HIV and AIDS ...
... symptoms of post-traumatic stress disorder, is no more effective than ... the San Francisco VA Medical Center. ,“There was ... effects,” says lead author Thomas Neylan, MD, medical director of ... PTSD should probably stay away from this drug and others ...
Cached Medicine News:Health News:Enzyme to Boost Effect of Tumor Vaccine 2Health News:Magnets in Commercial Products may Cause a Fatal Attraction 2Health News:Tennis Elbow is Not Caused Due to Improperly Sized Tennis Racket Grip 2Health News:Tennis Elbow is Not Caused Due to Improperly Sized Tennis Racket Grip 3Health News:'Drug Holidays' Increases Death Risk in HIV Patients 2Health News:Common PTSD Drug is No More Effective Than Placebo 2
... AST (GOT) powder reagent once reconstituted offers ... liquid stability to help maximize laboratory productivity, ... turnaround time. The patented technology of the ... long shelf life and stability once reconstituted ...
LCD chart display...
... are extremely delicate and if repairs are ... can easily be damaged beyond repair and ... , On the other hand, with conscientious ... have a virtually indefinite lifespan. The very ...
Mobile offers full life cycle service for Sp02 accessories that are the vital link between pulse oximeter and patient...
Medicine Products: